Global Medical Cannabis Market Research Report 2020

Global Medical Cannabis Market Research Report 2020

Table of Contents
1 Medical Cannabis Market Overview
1.1 Product Overview and Scope of Medical Cannabis
1.2 Medical Cannabis Segment by Type
1.2.1 Global Medical Cannabis Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tetrahydrocannabinol (THC)
1.2.3 Cannabidiol (CBD)
1.3 Medical Cannabis Segment by Application
1.3.1 Medical Cannabis Sales Comparison by Application: 2020 VS 2026
1.3.2 Pain
1.3.3 Arthritis
1.3.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.5 Others
1.4 Global Medical Cannabis Market Size Estimates and Forecasts
1.4.1 Global Medical Cannabis Revenue 2015-2026
1.4.2 Global Medical Cannabis Sales 2015-2026
1.4.3 Medical Cannabis Market Size by Region: 2020 Versus 2026
2 Global Medical Cannabis Market Competition by Manufacturers
2.1 Global Medical Cannabis Sales Market Share by Manufacturers (2015-2020)
2.2 Global Medical Cannabis Revenue Share by Manufacturers (2015-2020)
2.3 Global Medical Cannabis Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Medical Cannabis Manufacturing Sites, Area Served, Product Type
2.5 Medical Cannabis Market Competitive Situation and Trends
2.5.1 Medical Cannabis Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Medical Cannabis Players (Opinion Leaders)
3 Medical Cannabis Retrospective Market Scenario by Region
3.1 Global Medical Cannabis Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Medical Cannabis Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Medical Cannabis Market Facts & Figures by Country
3.3.1 North America Medical Cannabis Sales by Country
3.3.2 North America Medical Cannabis Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Medical Cannabis Market Facts & Figures by Country
3.4.1 Europe Medical Cannabis Sales by Country
3.4.2 Europe Medical Cannabis Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Medical Cannabis Market Facts & Figures by Region
3.5.1 Asia Pacific Medical Cannabis Sales by Region
3.5.2 Asia Pacific Medical Cannabis Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Medical Cannabis Market Facts & Figures by Country
3.6.1 Latin America Medical Cannabis Sales by Country
3.6.2 Latin America Medical Cannabis Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Medical Cannabis Market Facts & Figures by Country
3.7.1 Middle East and Africa Medical Cannabis Sales by Country
3.7.2 Middle East and Africa Medical Cannabis Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Medical Cannabis Historic Market Analysis by Type
4.1 Global Medical Cannabis Sales Market Share by Type (2015-2020)
4.2 Global Medical Cannabis Revenue Market Share by Type (2015-2020)
4.3 Global Medical Cannabis Price Market Share by Type (2015-2020)
4.4 Global Medical Cannabis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Medical Cannabis Historic Market Analysis by Application
5.1 Global Medical Cannabis Sales Market Share by Application (2015-2020)
5.2 Global Medical Cannabis Revenue Market Share by Application (2015-2020)
5.3 Global Medical Cannabis Price by Application (2015-2020)
6 Company Profiles and Key Figures in Medical Cannabis Business
6.1 BOL Pharma
6.1.1 Corporation Information
6.1.2 BOL Pharma Description, Business Overview and Total Revenue
6.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.1.4 BOL Pharma Products Offered
6.1.5 BOL Pharma Recent Development
6.2 Tilray
6.2.1 Tilray Medical Cannabis Production Sites and Area Served
6.2.2 Tilray Description, Business Overview and Total Revenue
6.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Tilray Products Offered
6.2.5 Tilray Recent Development
6.3 Medreleaf Corporation
6.3.1 Medreleaf Corporation Medical Cannabis Production Sites and Area Served
6.3.2 Medreleaf Corporation Description, Business Overview and Total Revenue
6.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Medreleaf Corporation Products Offered
6.3.5 Medreleaf Corporation Recent Development
6.4 Aurora Cannabis, Inc
6.4.1 Aurora Cannabis, Inc Medical Cannabis Production Sites and Area Served
6.4.2 Aurora Cannabis, Inc Description, Business Overview and Total Revenue
6.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aurora Cannabis, Inc Products Offered
6.4.5 Aurora Cannabis, Inc Recent Development
6.5 Canopy Growth Corporation
6.5.1 Canopy Growth Corporation Medical Cannabis Production Sites and Area Served
6.5.2 Canopy Growth Corporation Description, Business Overview and Total Revenue
6.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Canopy Growth Corporation Products Offered
6.5.5 Canopy Growth Corporation Recent Development
6.6 Insys Therapeutics, Inc
6.6.1 Insys Therapeutics, Inc Medical Cannabis Production Sites and Area Served
6.6.2 Insys Therapeutics, Inc Description, Business Overview and Total Revenue
6.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Insys Therapeutics, Inc Products Offered
6.6.5 Insys Therapeutics, Inc Recent Development
6.7 Aphria, Inc
6.6.1 Aphria, Inc Medical Cannabis Production Sites and Area Served
6.6.2 Aphria, Inc Description, Business Overview and Total Revenue
6.6.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aphria, Inc Products Offered
6.7.5 Aphria, Inc Recent Development
6.8 MGC Pharmaceuticals Limited
6.8.1 MGC Pharmaceuticals Limited Medical Cannabis Production Sites and Area Served
6.8.2 MGC Pharmaceuticals Limited Description, Business Overview and Total Revenue
6.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.8.4 MGC Pharmaceuticals Limited Products Offered
6.8.5 MGC Pharmaceuticals Limited Recent Development
6.9 GW Pharmaceuticals, plc
6.9.1 GW Pharmaceuticals, plc Medical Cannabis Production Sites and Area Served
6.9.2 GW Pharmaceuticals, plc Description, Business Overview and Total Revenue
6.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.9.4 GW Pharmaceuticals, plc Products Offered
6.9.5 GW Pharmaceuticals, plc Recent Development
6.10 Medical Marijuana Inc
6.10.1 Medical Marijuana Inc Medical Cannabis Production Sites and Area Served
6.10.2 Medical Marijuana Inc Description, Business Overview and Total Revenue
6.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Medical Marijuana Inc Products Offered
6.10.5 Medical Marijuana Inc Recent Development
7 Medical Cannabis Manufacturing Cost Analysis
7.1 Medical Cannabis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Medical Cannabis
7.4 Medical Cannabis Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Medical Cannabis Distributors List
8.3 Medical Cannabis Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Medical Cannabis Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Medical Cannabis by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Medical Cannabis by Type (2021-2026)
10.2 Medical Cannabis Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Medical Cannabis by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Medical Cannabis by Application (2021-2026)
10.3 Medical Cannabis Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Medical Cannabis by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Medical Cannabis by Region (2021-2026)
10.4 North America Medical Cannabis Estimates and Projections (2021-2026)
10.5 Europe Medical Cannabis Estimates and Projections (2021-2026)
10.6 Asia Pacific Medical Cannabis Estimates and Projections (2021-2026)
10.7 Latin America Medical Cannabis Estimates and Projections (2021-2026)
10.8 Middle East and Africa Medical Cannabis Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Medical Cannabis Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Medical Cannabis Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Medical Cannabis Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Medical Cannabis Manufacturers Covered in This Study
Table 5. Global Medical Cannabis Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Medical Cannabis Sales Share by Manufacturers (2015-2020)
Table 7. Global Medical Cannabis Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Medical Cannabis Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Medical Cannabis Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Medical Cannabis Sales Sites and Area Served
Table 11. Manufacturers Medical Cannabis Product Types
Table 12. Global Medical Cannabis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Medical Cannabis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Cannabis as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Medical Cannabis Players
Table 16. Global Medical Cannabis Sales (MT) by Region (2015-2020)
Table 17. Global Medical Cannabis Sales Market Share by Region (2015-2020)
Table 18. Global Medical Cannabis Revenue (Million US$) by Region (2015-2020)
Table 19. Global Medical Cannabis Revenue Market Share by Region (2015-2020)
Table 20. North America Medical Cannabis Sales by Country (2015-2020) (MT)
Table 21. North America Medical Cannabis Sales Market Share by Country (2015-2020)
Table 22. North America Medical Cannabis Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Medical Cannabis Revenue Market Share by Country (2015-2020)
Table 24. Europe Medical Cannabis Sales by Country (2015-2020) (MT)
Table 25. Europe Medical Cannabis Sales Market Share by Country (2015-2020)
Table 26. Europe Medical Cannabis Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Medical Cannabis Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Medical Cannabis Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Medical Cannabis Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Medical Cannabis Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Medical Cannabis Revenue Market Share by Region (2015-2020)
Table 32. Latin America Medical Cannabis Sales by Country (2015-2020) (MT)
Table 33. Latin America Medical Cannabis Sales Market Share by Country (2015-2020)
Table 34. Latin America Medical Cannabis Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Medical Cannabis Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Medical Cannabis Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Medical Cannabis Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Medical Cannabis Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Medical Cannabis Revenue Market Share by Country (2015-2020)
Table 40. Global Medical Cannabis Sales (MT) by Type (2015-2020)
Table 41. Global Medical Cannabis Sales Share by Type (2015-2020)
Table 42. Global Medical Cannabis Revenue (Million US$) by Type (2015-2020)
Table 43. Global Medical Cannabis Revenue Share by Type (2015-2020)
Table 44. Global Medical Cannabis Price (USD/MT) by Type (2015-2020)
Table 45. Global Medical Cannabis Sales (MT) by Application (2015-2020)
Table 46. Global Medical Cannabis Sales Market Share by Application (2015-2020)
Table 47. Global Medical Cannabis Sales Growth Rate by Application (2015-2020)
Table 48. BOL Pharma Medical Cannabis Corporation Information
Table 49. BOL Pharma Description and Business Overview
Table 50. BOL Pharma Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. BOL Pharma Main Product
Table 52. BOL Pharma Recent Development
Table 53. Tilray Medical Cannabis Corporation Information
Table 54. Tilray Corporation Information
Table 55. Tilray Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Tilray Main Product
Table 57. Tilray Recent Development
Table 58. Medreleaf Corporation Medical Cannabis Corporation Information
Table 59. Medreleaf Corporation Corporation Information
Table 60. Medreleaf Corporation Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Medreleaf Corporation Main Product
Table 62. Medreleaf Corporation Recent Development
Table 63. Aurora Cannabis, Inc Medical Cannabis Corporation Information
Table 64. Aurora Cannabis, Inc Corporation Information
Table 65. Aurora Cannabis, Inc Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Aurora Cannabis, Inc Main Product
Table 67. Aurora Cannabis, Inc Recent Development
Table 68. Canopy Growth Corporation Medical Cannabis Corporation Information
Table 69. Canopy Growth Corporation Corporation Information
Table 70. Canopy Growth Corporation Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Canopy Growth Corporation Main Product
Table 72. Canopy Growth Corporation Recent Development
Table 73. Insys Therapeutics, Inc Medical Cannabis Corporation Information
Table 74. Insys Therapeutics, Inc Corporation Information
Table 75. Insys Therapeutics, Inc Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Insys Therapeutics, Inc Main Product
Table 77. Insys Therapeutics, Inc Recent Development
Table 78. Aphria, Inc Medical Cannabis Corporation Information
Table 79. Aphria, Inc Corporation Information
Table 80. Aphria, Inc Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Aphria, Inc Main Product
Table 82. Aphria, Inc Recent Development
Table 83. MGC Pharmaceuticals Limited Medical Cannabis Corporation Information
Table 84. MGC Pharmaceuticals Limited Corporation Information
Table 85. MGC Pharmaceuticals Limited Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. MGC Pharmaceuticals Limited Main Product
Table 87. MGC Pharmaceuticals Limited Recent Development
Table 88. GW Pharmaceuticals, plc Medical Cannabis Corporation Information
Table 89. GW Pharmaceuticals, plc Corporation Information
Table 90. GW Pharmaceuticals, plc Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. GW Pharmaceuticals, plc Main Product
Table 92. GW Pharmaceuticals, plc Recent Development
Table 93. Medical Marijuana Inc Medical Cannabis Corporation Information
Table 94. Medical Marijuana Inc Corporation Information
Table 95. Medical Marijuana Inc Medical Cannabis Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Medical Marijuana Inc Main Product
Table 97. Medical Marijuana Inc Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Medical Cannabis Distributors List
Table 101. Medical Cannabis Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Medical Cannabis Sales (MT) Forecast by Type (2021-2026)
Table 106. Global Medical Cannabis Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Medical Cannabis Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Medical Cannabis Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Medical Cannabis Sales (MT) Forecast by Application (2021-2026)
Table 110. Global Medical Cannabis Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Medical Cannabis Sales (MT) Forecast by Region (2021-2026)
Table 112. Global Medical Cannabis Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Medical Cannabis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Medical Cannabis Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Medical Cannabis
Figure 2. Global Medical Cannabis Sales Market Share by Type: 2020 VS 2026
Figure 3. Tetrahydrocannabinol (THC) Product Picture
Figure 4. Cannabidiol (CBD) Product Picture
Figure 5. Global Medical Cannabis Consumption Market Share by Application: 2020 VS 2026
Figure 6. Pain
Figure 7. Arthritis
Figure 8. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Figure 9. Others
Figure 10. Global Medical Cannabis Market Size 2015-2026 (US$ Million)
Figure 11. Global Medical Cannabis Sales Capacity (MT) (2015-2026)
Figure 12. Global Medical Cannabis Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Medical Cannabis Sales Share by Manufacturers in 2020
Figure 14. Global Medical Cannabis Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Medical Cannabis Revenue in 2019
Figure 16. Medical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Medical Cannabis Sales Market Share by Region (2015-2020)
Figure 18. Global Medical Cannabis Sales Market Share by Region in 2019
Figure 19. Global Medical Cannabis Revenue Market Share by Region (2015-2020)
Figure 20. Global Medical Cannabis Revenue Market Share by Region in 2019
Figure 21. North America Medical Cannabis Sales Market Share by Country in 2019
Figure 22. North America Medical Cannabis Revenue Market Share by Country in 2019
Figure 23. U.S. Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 24. U.S. Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Medical Cannabis Sales Market Share by Country in 2019
Figure 28. Europe Medical Cannabis Revenue Market Share by Country in 2019
Figure 29. Germany Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 30. Germany Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 32. France Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 34. U.K. Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 36. Italy Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 38. Russia Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Medical Cannabis Sales Market Share by Region in 2019
Figure 40. Asia Pacific Medical Cannabis Revenue Market Share by Region in 2019
Figure 41. China Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 42. China Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 44. Japan Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 46. South Korea Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 48. India Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 50. Australia Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 52. Taiwan Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 54. Indonesia Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 56. Thailand Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 58. Malaysia Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 60. Philippines Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 62. Vietnam Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Medical Cannabis Sales Market Share by Country in 2019
Figure 64. Latin America Medical Cannabis Revenue Market Share by Country in 2019
Figure 65. Mexico Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 66. Mexico Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 68. Brazil Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 70. Argentina Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Medical Cannabis Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Medical Cannabis Revenue Market Share by Country in 2019
Figure 73. Turkey Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 74. Turkey Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 76. Saudi Arabia Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Medical Cannabis Sales Growth Rate (2015-2020) (MT)
Figure 78. U.A.E Medical Cannabis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Medical Cannabis by Type (2015-2020)
Figure 80. Sales Market Share of Medical Cannabis by Type in 2019
Figure 81. Revenue Share of Medical Cannabis by Type (2015-2020)
Figure 82. Revenue Market Share of Medical Cannabis by Type in 2019
Figure 83. Global Medical Cannabis Sales Growth by Type (2015-2020) (MT)
Figure 84. Global Medical Cannabis Sales Market Share by Application (2015-2020)
Figure 85. Global Medical Cannabis Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Medical Cannabis by Application (2015-2020)
Figure 87. Global Revenue Share of Medical Cannabis by Application in 2020
Figure 88. BOL Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Tilray Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Medreleaf Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Aurora Cannabis, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Canopy Growth Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Insys Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Aphria, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. MGC Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. GW Pharmaceuticals, plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Medical Marijuana Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Medical Cannabis
Figure 100. Manufacturing Process Analysis of Medical Cannabis
Figure 101. Medical Cannabis Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Medical Cannabis Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 106. North America Medical Cannabis Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Medical Cannabis Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Medical Cannabis Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Medical Cannabis Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Medical Cannabis Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Medical Cannabis Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Medical Cannabis Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Medical Cannabis Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Medical Cannabis Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs